Welcome to
HabPharmaceuticals
LOADING
U99999MH1997PLC105340
A – 301, Peninsula Business Park, Ganpatroa Kadam Marg, Lower Parel, Mumbai, India – 400013
A – 301, Peninsula Business Park, Ganpatroa Kadam Marg, Lower Parel, Mumbai, India – 400013
Chairman and Managing Director
Mr. Krishnakumar Agarwal is the Chairman and Managing Director of HAB Pharmaceuticals & Research Limited and the driving force behind the company’s journey since its inception. A postgraduate in Chemistry from Agra University, he founded HAB Pharma with a clear vision—to build a pharmaceutical organization that delivers quality healthcare products while creating long-term value for customers, employees, partners, and society.
Over the years, Mr. Agarwal has played a hands-on role in virtually every aspect of the business. His deep understanding of the pharmaceutical industry, coupled with his entrepreneurial mindset, has helped shape HAB Pharma into a trusted and growing healthcare organization. While his leadership extends across all business functions, his core strengths lie in strategic procurement, supply chain management, and institutional sales—areas that have served as the backbone of the company’s growth and stability.
With decades of industry experience, Mr. Agarwal has built strong relationships across the pharmaceutical value chain, including suppliers, healthcare institutions, government organizations, and business partners. His ability to identify opportunities, negotiate effectively, and build lasting partnerships has enabled the company to strengthen its market presence while maintaining high standards of quality and reliability.
Known for his practical approach, sharp business acumen, and unwavering commitment to ethical business practices, Mr. Agarwal has always believed that sustainable growth comes from trust, consistency, and long-term relationships. Under his leadership, HAB Pharma has expanded its product portfolio, strengthened its manufacturing capabilities, and established a presence across domestic and international markets.
Despite the company’s growth, Mr. Agarwal continues to remain closely involved in key business decisions and strategic planning. His leadership style combines experience, humility, and a strong focus on execution, inspiring teams across the organization to strive for excellence every day.
His vision for HAB Pharmaceuticals remains simple yet ambitious—to build a globally respected pharmaceutical company that delivers high-quality, affordable healthcare solutions while upholding the highest standards of integrity, quality, and customer commitment.
Chairman and Managing Director
Director
Mr. Sanjiv Garg is the Director and Co-Founder of HAB Pharmaceuticals & Research Limited and has played a defining role in the company’s growth journey since its early years. A graduate in Chemistry from Mumbai University, Mr. Garg brings with him decades of rich industry experience, particularly in the areas of sales, distribution, and international business development. His strategic thinking, market understanding, and relationship-driven approach have been instrumental in establishing HAB Pharma as a trusted name across domestic and global markets.
Widely recognized for his exceptional strength in exports and international business expansion, Mr. Garg has been one of the key driving forces behind HAB Pharma’s growing global presence. Under his leadership, the company has successfully expanded its footprint across multiple international markets including the Middle East, Africa, Europe, Asia, and America. His deep understanding of export business dynamics, regulatory requirements, and international market behavior has helped HAB build long-standing partnerships and a strong reputation across global pharmaceutical markets.
From the very beginning, Mr. Garg has been closely involved in strengthening the company’s sales and distribution network and establishing efficient business processes that support sustainable growth. His practical business approach, strong execution capabilities, and focus on operational discipline have helped create a robust distribution ecosystem for the organization both in India and overseas.
Known for his calm leadership style, ethical business values, and commitment to excellence, Mr. Garg strongly believes in building relationships based on trust, consistency, and long-term collaboration. His ability to identify emerging opportunities and convert them into sustainable business growth has contributed significantly to HAB Pharma’s evolution into a globally expanding pharmaceutical company.
Over the years, he has remained deeply involved in strategic planning, export expansion, customer relationships, and market development initiatives. His passion for international business and dedication toward strengthening HAB’s global reach continue to inspire teams across the organization.
At HAB Pharmaceuticals, Mr. Garg continues to play a vital role in driving the company’s international growth strategy while reinforcing the organization’s core values of quality, reliability, and customer commitment. His vision and leadership remain central to HAB Pharma’s ambition of becoming a globally respected pharmaceutical brand with a strong presence across regulated and emerging markets.
Director
Director
Mr. Saurabh Agrawal is the Director of HAB Pharmaceuticals & Research Limited and represents the next phase of leadership shaping the company’s growth with speed, strategic clarity, and strong execution discipline. In his role, he leads new business development initiatives while overseeing the company’s marketing strategy and business planning, ensuring alignment between market opportunity, operational readiness, and long-term organisational goals.
With over 18 years of experience in the pharmaceutical industry, Mr. Agrawal has played a key role in building and sustaining partnerships across the value chain, including customers, suppliers, distributors, and regulatory stakeholders. He has been closely involved in the launch and scale-up of multiple high-quality products, contributing to both the company’s reputation and its commercial performance. His approach combines sharp market insight with structured planning, enabling the organisation to respond quickly to evolving market needs while maintaining quality and compliance benchmarks.
Widely regarded as a dynamic and progressive leader, Mr. Agrawal brings a strong execution mindset to the business. His core strengths lie in market analysis, contract negotiation, product development, customer relationship management, and operational optimization. He actively focuses on strengthening production efficiency, streamlining operations, and embedding robust systems that support sustainable scale-up. Known for his energetic leadership style and forward-looking thinking, he continuously works to reinforce the organization’s core values and institutional foundations.
Carrying forward the entrepreneurial legacy of HAB Pharma, Mr. Agrawal combines inherited business acumen with contemporary strategic thinking to give the company a competitive edge. His vision is firmly anchored in building a future-ready pharmaceutical organisation—one that delivers value to markets responsibly, adheres to the highest standards of quality, safety, and ethics, and steadily advances toward its ambition of becoming a globally respected pharmaceutical company.
Director
Director
Ms. Urvee Garg is a Director at HAB Pharmaceuticals & Research Limited and is actively involved in strengthening the organization’s regulatory, human resources, and international business functions. As a member of the next generation of leadership, she combines professional pharmaceutical knowledge with a modern management approach, helping the company build strong systems, enhance compliance standards, and support sustainable global growth.
A qualified pharmacist, Ms. Garg began her professional journey with reputed organizations such as Piramal Healthcare and AstraZeneca, where she gained valuable exposure to global pharmaceutical practices, regulatory frameworks, quality systems, and structured business processes. These experiences provided her with a strong foundation that she now leverages to support HAB Pharma’s evolving business and organizational objectives.
At HAB Pharmaceuticals, Ms. Garg plays a key role in overseeing regulatory affairs, export coordination, and human resource initiatives. She works closely with cross-functional teams to ensure compliance with regulatory requirements across various markets while supporting the company’s expanding international footprint. Her involvement in export operations helps facilitate smooth coordination between customers, regulatory agencies, and internal departments, ensuring timely execution and adherence to market-specific requirements.
In addition to her regulatory and export responsibilities, Ms. Garg is deeply involved in strengthening the organization’s people and culture initiatives. She actively contributes to talent development, employee engagement, organizational policies, and HR processes that support a high-performance and values-driven work environment. She believes that strong organizations are built on strong people and is committed to fostering a culture of collaboration, accountability, and continuous learning.
Known for her detail-oriented approach, strong interpersonal skills, and commitment to excellence, Ms. Garg brings a balanced perspective that combines compliance, people management, and business growth. Her ability to work across diverse functions enables her to contribute effectively to the company’s strategic objectives while ensuring operational discipline and organizational alignment.
As HAB Pharmaceuticals continues to expand its presence in global markets, Ms. Garg remains focused on strengthening regulatory excellence, developing talent, and supporting international growth initiatives. Through her leadership and dedication, she continues to contribute to HAB Pharma’s vision of becoming a globally respected pharmaceutical organization built on quality, integrity, and innovation.
Director
Director
Mrs. Vinita Krishnakumar Agarwal serves as a Director on the Board of HAB Pharmaceuticals & Research Ltd., where she contributes significantly to the Company’s strategic direction and long-term growth. With a strong academic foundation in Economics and a deep understanding of business dynamics, she plays an instrumental role in guiding the Company’s vision, governance, and sustainable development initiatives.
As a member of the Board, she provides valuable insights into strategic planning, policy formulation, and organizational decision-making. Her analytical approach and balanced perspective enable the Company to identify emerging opportunities, manage business risks effectively, and build resilient growth strategies in an evolving pharmaceutical landscape.
Mrs. Agarwal actively supports the leadership team in strengthening corporate governance practices and fostering a culture of accountability, innovation, and operational excellence. Her focus on sustainable value creation ensures that the Company’s growth remains aligned with the interests of its stakeholders, employees, customers, and business partners.
She holds a Master of Arts (M.A.) in Economics, and her academic expertise complements her strategic contributions to the Company’s continued success. Through her guidance and commitment, she continues to support HAB Pharmaceuticals & Research Ltd. in its mission to deliver high-quality pharmaceutical solutions while maintaining the highest standards of integrity, governance, and corporate responsibility.
Director
Director
Mrs. Renu Garg serves as a Director on the Board of HAB Pharmaceuticals & Research Ltd., contributing to the Company’s strategic leadership and long-term vision. With a strong academic background in Chemistry, she brings a scientific perspective that complements the Company’s commitment to quality, innovation, and excellence in the pharmaceutical industry.
As a member of the Board, Mrs. Garg plays a key role in supporting strategic planning, corporate governance, and policy formulation. Her balanced approach and thoughtful insights contribute to informed decision-making, enabling the Company to navigate evolving industry dynamics while maintaining a strong focus on sustainable growth and operational excellence.
She actively supports initiatives that strengthen organizational performance, promote ethical business practices, and reinforce the Company’s commitment to delivering safe, effective, and high-quality healthcare solutions. Her contributions help foster a culture of accountability, continuous improvement, and stakeholder value creation.
Mrs. Garg’s scientific foundation, combined with her strategic outlook, enables her to provide meaningful guidance to the Board as HAB Pharmaceuticals & Research Ltd. continues to expand its presence in domestic and international markets. Her commitment to the Company’s values and long-term objectives supports HAB Pharma’s mission of improving lives through trusted and affordable pharmaceutical products.
Director
